funded baby vaccine trial blasted by WHO is drawing significant interest across the industry.
Giving some newborns in Guinea-Bissau an established hepatitis B treatment but not others is "unethical", it says.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →